Also trades as: 4967.T (JPX) · $vol 12M
KBYPF OTC
Kobayashi Pharmaceutical Co., Ltd.
1W: +15.9%
1M: +15.9%
3M: +15.9%
YTD: +14.0%
1Y: +5.5%
3Y: -26.9%
5Y: -51.5%
$39.47
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$25.6B
+127.7% ▲
5Y CAGR: +1.3%
Capital Expenditures
$13.3B
+50.2% ▲
5Y CAGR: +26.2%
Free Cash Flow
$12.3B
+180.3% ▲
5Y CAGR: -9.0%
Dividends Paid
$7.7B
-2.1% ▼
Buybacks
$0
+0.0% ▲
Net Change in Cash
$16.5B
+220.3% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $27.6B | $27.9B | $27.6B | $13.9B | $3.7B |
| Depreciation & Amort. | $4.8B | $5.4B | $6.1B | $8.0B | $8.8B |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$2.1B | $6.8B | -$6.6B | -$1.8B | $7.8B |
| Other Non-Cash Items | -$7.9B | -$8.2B | -$8.7B | -$8.8B | $5.4B |
| Operating Cash Flow | $22.4B | $31.9B | $18.4B | $11.2B | $25.6B |
| — Investing Activities — | |||||
| Capital Expenditures | -$4.2B | -$16.2B | -$12.8B | -$26.1B | -$14.0B |
| Acquisitions (Net) | $200M | -$1.5B | -$11.2B | $0 | $2.6B |
| Investment Purchases | -$49.5B | -$49.6B | -$49.4B | -$32.3B | -$26.0B |
| Investment Sales | $61.6B | $51.8B | $54.7B | $40.4B | $36.9B |
| Other Investing | -$119M | $1.2B | -$1.0B | -$412M | $299M |
| Investing Cash Flow | $8.0B | -$14.3B | -$19.6B | -$18.4B | -$154M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$12M | -$1M | $0 | $0 | $0 |
| Stock Repurchased | -$3.9B | -$14.1B | -$12.0B | $0 | $0 |
| Dividends Paid | -$6.3B | -$6.5B | -$7.2B | -$7.5B | -$7.7B |
| Other Financing | -$171M | -$193M | -$240M | -$263M | -$268M |
| Financing Cash Flow | -$10.4B | -$20.8B | -$19.5B | -$7.8B | -$7.9B |
| Net Change in Cash | $20.8B | -$2.5B | -$19.8B | -$13.7B | $16.5B |
| Cash End of Period | $82.0B | $79.5B | $59.7B | $46.0B | $62.4B |
| Free Cash Flow | $18.2B | $15.7B | $4.8B | -$15.4B | $12.3B |